First Time Loading...

Ovoca Bio PLC
LSE:OVB

Watchlist Manager
Ovoca Bio PLC Logo
Ovoca Bio PLC
LSE:OVB
Watchlist
Price: 0.8 GBX 10.34% Market Closed
Updated: May 21, 2024

Intrinsic Value

OVB doesn't have a meaningful market cap.
OVB's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. [ Read More ]

The intrinsic value of one OVB stock under the Base Case scenario is 4.86 GBX. Compared to the current market price of 0.8 GBX, Ovoca Bio PLC is Undervalued by 84%.

Key Points:
OVB Intrinsic Value
Base Case
4.86 GBX
Undervaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Ovoca Bio PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OVB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Ovoca Bio PLC

Provide an overview of the primary business activities
of Ovoca Bio PLC.

What unique competitive advantages
does Ovoca Bio PLC hold over its rivals?

What risks and challenges
does Ovoca Bio PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ovoca Bio PLC.

Provide P/S
for Ovoca Bio PLC.

Provide P/E
for Ovoca Bio PLC.

Provide P/OCF
for Ovoca Bio PLC.

Provide P/FCFE
for Ovoca Bio PLC.

Provide P/B
for Ovoca Bio PLC.

Provide EV/S
for Ovoca Bio PLC.

Provide EV/GP
for Ovoca Bio PLC.

Provide EV/EBITDA
for Ovoca Bio PLC.

Provide EV/EBIT
for Ovoca Bio PLC.

Provide EV/OCF
for Ovoca Bio PLC.

Provide EV/FCFF
for Ovoca Bio PLC.

Provide EV/IC
for Ovoca Bio PLC.

What are the Revenue projections
for Ovoca Bio PLC?

How accurate were the past Revenue estimates
for Ovoca Bio PLC?

What are the Net Income projections
for Ovoca Bio PLC?

How accurate were the past Net Income estimates
for Ovoca Bio PLC?

What are the EPS projections
for Ovoca Bio PLC?

How accurate were the past EPS estimates
for Ovoca Bio PLC?

What are the EBIT projections
for Ovoca Bio PLC?

How accurate were the past EBIT estimates
for Ovoca Bio PLC?

Compare the revenue forecasts
for Ovoca Bio PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ovoca Bio PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ovoca Bio PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ovoca Bio PLC compared to its peers.

Compare the P/E ratios
of Ovoca Bio PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Ovoca Bio PLC with its peers.

Analyze the financial leverage
of Ovoca Bio PLC compared to its main competitors.

Show all profitability ratios
for Ovoca Bio PLC.

Provide ROE
for Ovoca Bio PLC.

Provide ROA
for Ovoca Bio PLC.

Provide ROIC
for Ovoca Bio PLC.

Provide ROCE
for Ovoca Bio PLC.

Provide Gross Margin
for Ovoca Bio PLC.

Provide Operating Margin
for Ovoca Bio PLC.

Provide Net Margin
for Ovoca Bio PLC.

Provide FCF Margin
for Ovoca Bio PLC.

Show all solvency ratios
for Ovoca Bio PLC.

Provide D/E Ratio
for Ovoca Bio PLC.

Provide D/A Ratio
for Ovoca Bio PLC.

Provide Interest Coverage Ratio
for Ovoca Bio PLC.

Provide Altman Z-Score Ratio
for Ovoca Bio PLC.

Provide Quick Ratio
for Ovoca Bio PLC.

Provide Current Ratio
for Ovoca Bio PLC.

Provide Cash Ratio
for Ovoca Bio PLC.

What is the historical Revenue growth
over the last 5 years for Ovoca Bio PLC?

What is the historical Net Income growth
over the last 5 years for Ovoca Bio PLC?

What is the current Free Cash Flow
of Ovoca Bio PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ovoca Bio PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ovoca Bio PLC

Current Assets 5m
Cash & Short-Term Investments 4.4m
Receivables 447k
Other Current Assets 132k
Non-Current Assets 6.4m
Long-Term Investments 262k
PP&E 21k
Intangibles 6.2m
Other Non-Current Assets 2k
Current Liabilities 2.4m
Accounts Payable 1.3m
Other Current Liabilities 1.2m
Non-Current Liabilities 292k
Other Non-Current Liabilities 292k
Efficiency

Earnings Waterfall
Ovoca Bio PLC

Revenue
0 EUR
Operating Expenses
-2.3m EUR
Operating Income
-2.3m EUR
Other Expenses
-47k EUR
Net Income
-2.3m EUR

Free Cash Flow Analysis
Ovoca Bio PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

OVB Profitability Score
Profitability Due Diligence

Ovoca Bio PLC's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

Ovoca Bio PLC's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

OVB Solvency Score
Solvency Due Diligence

Ovoca Bio PLC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
45/100
Solvency
Score

Ovoca Bio PLC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OVB Price Targets Summary
Ovoca Bio PLC

There are no price targets for OVB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Ovoca Bio PLC

Shareholder Return

OVB Price
Ovoca Bio PLC

1M 1M
+33%
6M 6M
-36%
1Y 1Y
-90%
3Y 3Y
-93%
5Y 5Y
-87%
10Y 10Y
-88%
Annual Price Range
0.8
52w Low
0.55
52w High
14
Price Metrics
Average Annual Return 13.55%
Standard Deviation of Annual Returns 68.23%
Max Drawdown -98%
Shares Statistics
Market Capitalization 652.5k GBX
Shares Outstanding 81 563 806
Percentage of Shares Shorted
N/A

OVB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Ovoca Bio PLC Logo
Ovoca Bio PLC

Country

Ireland

Industry

Pharmaceuticals

Market Cap

652.5k GBP

Dividend Yield

0%

Description

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The firm is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The firm operates in Ireland, the United Kingdom (UK) and Russia.

Contact

DUBLIN
DUBLIN
Dublin 2, 17 Pembroke Street Upper
+35316619819.0
https://ovocabio.com/

IPO

1987-04-21

Employees

5

Officers

Interim Chairman of the Board & CEO
Mr. Kirill Andreyevich Golovanov
Vice President of Finance
Mr. Dmitriy Nikitashenko
Corporate Secretary
Reneta Nikolova

See Also

Discover More
What is the Intrinsic Value of one OVB stock?

The intrinsic value of one OVB stock under the Base Case scenario is 4.86 GBX.

Is OVB stock undervalued or overvalued?

Compared to the current market price of 0.8 GBX, Ovoca Bio PLC is Undervalued by 84%.